| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/01/1992 | WO1992004377A1 HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
| 03/01/1992 | WO1992004034A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | WO1992003471A1 New insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | WO1992003470A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | WO1992003469A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090705A1 Genetic material encoding igfbp-5 |
| 03/01/1992 | CA2090704A1 Genetic material encoding igfbp-4 |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090702A1 Insulin-like growth factor binding protein igfbp-5 |
| 03/01/1992 | CA2090478A1 Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials |
| 03/01/1992 | CA2090464A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | CA2089761A1 Method and compositions for diagnosing and treating chronic fatique immunodysfunction syndrome |
| 03/01/1992 | CA2049883A1 Monoclonal antibody specifically reactive with human perforin |
| 02/28/1992 | WO1992003473A1 Cd18 peptide medicaments for the treatment of disease |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | CA2090486A1 Human zona pellucida protein zp3 |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2090427A1 Cd18 peptide medicaments for the treatment of disease |
| 02/26/1992 | WO1992003458A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/26/1992 | EP0472498A1 Monoclonal antibodies to leptosphaeria |
| 02/26/1992 | EP0472207A2 Hepatitis C assay utilizing recombinant antigens |
| 02/26/1992 | EP0471832A1 Improved expression of polypeptides |
| 02/26/1992 | EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| 02/26/1992 | EP0471759A1 HIGH LEVEL EXPRESSION OF FUNCTIONAL HUMAN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) IN $i(E. COLI) |
| 02/26/1992 | EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus |
| 02/26/1992 | EP0247145B1 Multiply-amplifiable vectors for high level expression of exogenous dna |
| 02/26/1992 | EP0218712B1 Novel procoagulant proteins |
| 02/26/1992 | CA2090335A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/25/1992 | US5091511 Lymphokine activated killer suppressive factor (LAKSF), process for producing it and immunosuppressive agent comprising it |
| 02/25/1992 | US5091364 Preparation of immunologically active cell wall components from archaebacteria |
| 02/25/1992 | US5091303 Binding of monoclonal antibody to pure p29 protein |
| 02/25/1992 | US5091177 Monoclonal antibodies for treatment of human non-small cell lung carcinomas |
| 02/25/1992 | CA1296275C Monoclonal antibody, hybridoma, their production and use thereof |
| 02/25/1992 | CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same |
| 02/25/1992 | CA1296271C Promoter arrangement for streptomycetes vectors |
| 02/24/1992 | CA2049538A1 Chondromodulin-i protein |
| 02/21/1992 | CA2049401A1 Heparin binding neurotrophic factor gene sequence |
| 02/21/1992 | CA2049370A1 Human mk gene and protein sequence |
| 02/20/1992 | WO1992002820A1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
| 02/20/1992 | WO1992002626A1 Eliminating internal initiation of soluble cd4 gene |
| 02/20/1992 | WO1992002623A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 02/20/1992 | WO1992002620A1 Chimeric neurotrophic factors |
| 02/20/1992 | WO1992002615A1 Serine protease variants having peptide ligase activity |
| 02/20/1992 | WO1992002612A2 Tissue plasminogen activator variants with decreased clearance |
| 02/20/1992 | WO1992002558A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 02/20/1992 | WO1992002556A1 Human colon cancer cell-derived fibroblast elongation factor |
| 02/20/1992 | WO1992002554A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/20/1992 | WO1992002553A1 Tumor cell binding molecule with protease inhibiting region |
| 02/20/1992 | WO1992002550A1 Expression of recombinant polypeptides with improved purification |
| 02/20/1992 | WO1992002539A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/20/1992 | WO1992002536A1 Systematic polypeptide evolution by reverse translation |
| 02/20/1992 | WO1992002246A1 Growth factor compositions, preparation and use |
| 02/20/1992 | WO1992002139A1 Insecticidal proteins |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | DE4025725A1 Monoklonale antikoerper, die mit human- und ratteninsulin bindefaehig sind Monoclonal antibodies that are human and rat insulin with bindefaehig |
| 02/20/1992 | CA2390512A1 Methods for the production of proteins with a desired function |
| 02/20/1992 | CA2088990A1 Chimeric neurotrophic factors |
| 02/20/1992 | CA2088164A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/19/1992 | EP0471564A2 Translational enhancement in pseudomonas |
| 02/19/1992 | EP0471453A2 Cyclic HIV principal neutralizing determinant peptides |
| 02/19/1992 | EP0471345A1 Determination of biogenous amines |
| 02/19/1992 | EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/18/1992 | WO1992003478A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | US5089605 Immobilized immunoglobulin-binding proteins |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/18/1992 | US5089481 Polysaccharides and antiviral drugs containing the same as active ingredient |
| 02/18/1992 | US5089473 Somatotropin variants and their use |
| 02/18/1992 | US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators |
| 02/18/1992 | US5089262 Diagnosis, therapy |
| 02/18/1992 | CA2087267A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | CA1295985C Method for separating and purifying protein antigens from bordetella bacteria |
| 02/18/1992 | CA1295960C Monoclonal antibody |
| 02/18/1992 | CA1295938C Monoclonal antibodies effective in promoting growth |
| 02/18/1992 | CA1295937C Method for the evaluation of oral microbes |
| 02/16/1992 | CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein |
| 02/14/1992 | WO1992003551A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | WO1992003466A1 Lymphokine 154 |
| 02/14/1992 | CA2089258A1 Lymphokine 154 |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/14/1992 | CA2067182A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/12/1992 | EP0470586A1 Purified recombinant interleukin-2 compositions |
| 02/12/1992 | EP0470565A1 Peptides with antigenic determinant characteristic for alpha 1-microglobulin |
| 02/12/1992 | EP0470520A2 Process for the preparation of peptides or polypeptides in a cell-free translation system |
| 02/12/1992 | EP0470175A1 Enzymatic membrane method for the synthesis and separation of peptides |
| 02/12/1992 | EP0470165A1 Fusion proteins containing n-terminal fragments of human serum albumin |
| 02/12/1992 | EP0094428B1 Control of dna sequence transcription |
| 02/12/1992 | CN1058597A Process for enzymatic preparation of basic fibroblast growth factor |
| 02/11/1992 | US5087615 Novel method of ovulation induction in humans |
| 02/11/1992 | US5087614 Inhibits aspartic proteinases |
| 02/11/1992 | US5087613 Hirudin variants |
| 02/11/1992 | US5087560 Monoclonal antibody for use in drug resistant cancers and production thereof |
| 02/11/1992 | US5087557 Human monoclonal antibody to lymphadenopathy-associated virus |
| 02/11/1992 | US5087369 Absorption using rotation affinity gel carrier |
| 02/11/1992 | CA1295785C Process for the preparation of aspartame and agents for carrying it out |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |
| 02/11/1992 | CA1295564C Recombinant plasmid inserted with herpes simplex virus gene |
| 02/11/1992 | CA1295562C DNA SEQUENCES CODING FOR THE DR.beta.-CHAIN LOCUS OF THE HUMAN LYMPHOCYTE ANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING PROCESSES AND PRODUCTS RELATED THERETO |
| 02/10/1992 | WO1992002629A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |